Literature DB >> 16198282

A public health action plan is needed for chronic kidney disease.

Anton C Schoolwerth1, Michael M Engelgau, Thomas H Hostetter.   

Abstract

In 2005, chronic kidney disease (CKD) meets all criteria for classification as a public health problem in the United States. It imposes a large burden on society that is increasing despite ongoing efforts to control the disease. The burden is unevenly distributed by race and economic status, whereas evidence suggests that preventive strategies could substantially reduce the burden. Finally, there are indications that such strategies are not yet in place. A broad and coordinated public health approach to the burgeoning health, economic, and societal challenges of CKD is needed to complement present clinical approaches, increase awareness, promote early detection, and facilitate prevention and treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16198282     DOI: 10.1053/j.ackd.2005.07.012

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  4 in total

1.  The H.U.G.E. Formula (Hematocrit, Urea, Sex) for Screening Chronic Kidney Disease (CKD) in an Age-Stratified General Population.

Authors:  N R Robles; F J Felix; L Lozano; I Miranda; D Fernandez-Berges; J F Macías
Journal:  J Nutr Health Aging       Date:  2015-06       Impact factor: 4.075

2.  In memorandum of world kidney day: chronic kidney disease: a common but often unnoticed major health problem.

Authors:  M K Fallahzadeh; M M Sagheb; M H Fallahzadeh
Journal:  Iran Red Crescent Med J       Date:  2011-03-01       Impact factor: 0.611

3.  Quality assessment of clinical practice guidelines for chronic kidney disease: a systematic review.

Authors:  Jorge Coronado Daza; Robin W M Vernooij; Karla Salas; Dimelza Osorio; Gerard Urrútia Cuchí
Journal:  BMC Nephrol       Date:  2019-05-28       Impact factor: 2.388

4.  Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation.

Authors:  Vanesa Esteban; Silvia Heringer-Walther; Anja Sterner-Kock; Ron de Bruin; Sandra van den Engel; Yong Wang; Sergio Mezzano; Jesus Egido; Heinz-Peter Schultheiss; Marta Ruiz-Ortega; Thomas Walther
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.